OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00291756

Shenzhen King Explorer Science and Technology Corp

Commodity ChemicalsVerified

The company maintains a relatively strong liquidity position, with a current ratio of 1.95, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its liquidity risk is assessed as medium, and it has negative net cash after subtracting total debt, suggesting potential pressure on its cash reserves. The debt-to-equity ratio of 0.27 indicates a conservative capital structure, with a relatively low proportion of debt compared to equity. In terms of profitability, the company reports a return on equity (ROE) of 10.22% and a return on assets (ROA) of 5.54%, both of which are above the typical thresholds for the Commodity Chemicals industry. These metrics suggest that the company is effectively utilizing its equity and assets to generate returns. The gross profit margin is 36.2%, and the operating margin is 14.0%, which are both in line with or slightly above the industry median for commodity chemical producers. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates. The company's growth trajectory is modest, with no specific revenue growth projections provided in the available data. However, the operating cash flow of 314.56 million CNY and free cash flow of 218.76 million CNY suggest that the company is generating positive cash from operations, which could support future growth initiatives or shareholder returns. The risk assessment indicates a low dilution risk, with no significant dilution potential identified in the basic shares outstanding. The company has not issued additional shares recently, and there is no indication of a pending equity offering or share buyback program. However, the negative net cash position and the presence of long-term debt may require the company to consider financing options in the near term, which could introduce dilution risk if equity is used. Recent events include the filing of its latest financial report, which provides a snapshot of its financial health and performance. No material events, such as mergers, acquisitions, or regulatory actions, have been disclosed in the available data. The company's capital expenditure for the period was negative, indicating that it may have sold assets or reduced its investment in fixed assets.

30-day price · 002917(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyShenzhen King Explorer Science and Technology Corp
Ticker002917.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shenzhen King Explorer Science and Technology Corp is a chemicals company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and manufacturing customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

The company maintains a relatively strong liquidity position, with a current ratio of 1.95, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its liquidity risk is assessed as medium, and it has negative net cash after subtracting total debt, suggesting potential pressure on its cash reserves. The debt-to-equity ratio of 0.27 indicates a conservative capital structure, with a relatively low proportion of debt compared to equity. In terms of profitability, the company reports a return on equity (ROE) of 10.22% and a return on assets (ROA) of 5.54%, both of which are above the typical thresholds for the Commodity Chemicals industry. These metrics suggest that the company is effectively utilizing its equity and assets to generate returns. The gross profit margin is 36.2%, and the operating margin is 14.0%, which are both in line with or slightly above the industry median for commodity chemical producers. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates. The company's growth trajectory is modest, with no specific revenue growth projections provided in the available data. However, the operating cash flow of 314.56 million CNY and free cash flow of 218.76 million CNY suggest that the company is generating positive cash from operations, which could support future growth initiatives or shareholder returns. The risk assessment indicates a low dilution risk, with no significant dilution potential identified in the basic shares outstanding. The company has not issued additional shares recently, and there is no indication of a pending equity offering or share buyback program. However, the negative net cash position and the presence of long-term debt may require the company to consider financing options in the near term, which could introduce dilution risk if equity is used. Recent events include the filing of its latest financial report, which provides a snapshot of its financial health and performance. No material events, such as mergers, acquisitions, or regulatory actions, have been disclosed in the available data. The company's capital expenditure for the period was negative, indicating that it may have sold assets or reduced its investment in fixed assets.
Key takeaways
  • The company has a strong current ratio of 1.95, indicating good short-term liquidity.
  • ROE of 10.22% and ROA of 5.54% suggest efficient use of equity and assets.
  • The company's capital structure is conservative, with a debt-to-equity ratio of 0.27.
  • Revenue is concentrated in a single business segment, increasing exposure to market fluctuations.
  • The company generates positive operating and free cash flows, supporting potential growth or shareholder returns.
  • The company has a low dilution risk, but its negative net cash position may require financing in the near term.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.77B
Gross profit$640.5M
Operating income$247.9M
Net income$174.6M
R&D
SG&A
D&A
SBC
Operating cash flow$314.6M
CapEx-$20.6M
Free cash flow$218.8M
Total assets$3.15B
Total liabilities$1.44B
Total equity$1.71B
Cash & equivalents
Long-term debt$460.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.77B$247.9M$174.6M$218.8M
FY-1$1.63B$165.0M$124.1M$149.0M
FY-2$1.51B$116.5M$101.7M$84.3M
FY-3$1.19B-$20.0M$25.3M-$136.3M
FY-4$815.1M$29.2M$39.9M$5.0M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$3.15B$1.71B
FY-1$3.19B$1.57B
FY-2$3.17B$1.51B
FY-3$3.06B$1.45B
FY-4$2.15B$769.9M
PeriodOCFCapExFCFSBC
FY0$314.6M-$20.6M$218.8M
FY-1$141.3M-$20.3M$149.0M
FY-2$143.0M-$52.5M$84.3M
FY-3-$28.3M-$135.7M-$136.3M
FY-4$30.1M-$34.2M$5.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$362.7M$48.8M$38.4M
FQ-1$523.5M$67.6M$41.7M
FQ-2$420.8M$66.9M$46.1M
FQ-3$462.7M$70.4M$51.0M
FQ-4$362.1M$43.1M$35.7M
FQ-5$453.5M$24.0M$16.4M
FQ-6$432.1M$48.3M$35.9M
FQ-7$428.8M$74.3M$57.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$3.13B$1.75B$361.0M
FQ-1$3.15B$1.71B
FQ-2$3.21B$1.68B$244.4M
FQ-3$3.28B$1.67B
FQ-4$3.16B$1.62B$361.3M
FQ-5$3.19B$1.57B
FQ-6$3.06B$1.56B$192.2M
FQ-7$3.17B$1.56B
PeriodOCFCapExFCFSBC
FQ0-$15.8M-$2.8M
FQ-1$314.6M-$20.6M
FQ-2$205.5M-$15.4M
FQ-3$142.9M-$11.9M
FQ-4$41.6M-$7.0M
FQ-5$141.3M-$20.3M
FQ-6$40.7M-$13.4M
FQ-7$58.8k-$9.7M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.71B
Net cash-$460.1M
Current ratio1.9
Debt/Equity0.3
ROA5.5%
ROE10.2%
Cash conversion1.8%
CapEx/Revenue-1.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002917Activity
Op margin14.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin9.9%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin36.2%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity27.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:36 UTCJob: e5b6761d